Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.

Background: Phospholipids and their metabolisms are closely allied to nosogenesis and aggravation of Type 2 diabetes mellitus and cognitive impairment. The aim of this study is to characterize the plasma levels of phospholipids in type 2 diabetes patients and type 2 diabetes patients with mild cognitive impairment (MCI), and to identify potential biomarkers of type 2 diabetes patients with MCI.

Methods: In this cross-sectional study, a total of 374 type 2 diabetes patients were prospectively enrolled.